American Well Corporation

NYSE:AMWL

Medical - Healthcare Information Services

Healthcare
$11.03 +2.82%

+$0.24 today

Market cap
$171.77M
Beta
1.70
P/E (TTM)
-1.6
EPS (TTM)
-$5.30
52W Low $3.71High $9.96

Volume 0.06M

Average 0.07M

AMWL Pre-Tax Margin

Income before tax as a percentage of revenue.

American Well CorporationNYSE: AMWL

Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026

Pre-tax margin widens to -18.4%

Pre-tax margin was -18.4% in Q1 FY2026, up 8.2 pp from a year earlier. On a trailing-twelve-month basis it was -36.6%, up 22.8 pp year over year. Over 3 fiscal years it widened by 60.2 pp.

Context

  • Pre-tax margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-18.4%+28.3 pp QoQ
Last fiscal yearDec 2025
-37.9%+44.6 pp YoY
LTMMar 2026
-36.6%+22.8 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+8.2 pp——
1 year+44.6 pp——
3 years+60.2 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
-37.9%
Year-over-year change
+44.6pp

Pre-Tax Margin vs competitors

How AMWL compares with its peers on the latest reported figures

  • AMWL's LTM Mar 2026 pre-tax margin of -36.6% is the 2nd highest of the 5 companies compared; the peer median is -1146.2%.
  • Its year-over-year change of +22.8 pp is the 2nd highest of 4, against a peer median of +5.0 pp.
  • Over three fiscal years its change of +60.2 pp compares with a peer median of +154.5 pp.
AMWL Competitors Peer median
Pre-Tax Margin for AMWL and competitors
Company Period LTM level YoY 3-year change
EUDAEUDA Health Holdings LimitedLTM Jun 2026-35.6% +5.0 pp+622.4 pp
AMWLAmerican Well CorporationLTM Mar 2026-36.6% +22.8 pp+60.2 pp
DTILPrecision BioSciences, Inc.LTM Mar 2026-98.7% -55.7 pp+154.5 pp
CAMPCAMP4 Therapeutics CorporationLTM Mar 2026-2193.7% +1234.9 pp—
ATYRaTyr Pharma, Inc.LTM Mar 2026-36859.5% —-38572.9 pp
ALXOALX Oncology Holdings Inc.FY2025— ——
IMUXImmunic, Inc.FY2025— ——
BMEABiomea Fusion, Inc.FY2025— ——
GUTSFractyl Health, Inc. Common StockFY2025— ——
Peer median (excluding AMWL) -1146.2%+5.0 pp+154.5 pp

Competitors are the stored peer set for AMWL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue252.79M277.19M259.05M254.36M249.33M
Cost of Revenue148.47M160.42M164.29M155.41M116.47M
Gross Profit104.32M116.77M94.76M98.95M132.86M
Gross Margin41.3%42.1%36.6%38.9%53.3%
Research & Development106.59M138.49M105.83M86.07M72.86M
Selling, General & Admin160.78M227.98M213.11M197.45M131.31M
Operating Expenses283.46M392.62M786.9M316.49M238.13M
Depreciation & Amortization16.09M26.17M31.51M32.98M33.96M
EBITDA(166.07M)(245.84M)(224.15M)(176.91M)(60.57M)
EBITDA Margin-65.7%-88.7%-86.5%-69.6%-24.3%
Operating Income(179.15M)(275.85M)(692.14M)(217.53M)(105.27M)
Operating Margin-70.9%-99.5%-267.2%-85.5%-42.2%
Interest Income120K6.12M19.42M10.76M3.8M
Interest Expense00000
Other Income / Expenses(3.01M)3.85M16.83M7.65M10.74M
Income Before Tax(182.16M)(272.01M)(675.31M)(209.89M)(94.53M)
Pre-Tax Margin-72.1%-98.1%-260.7%-82.5%-37.9%
Income Tax Expense(5.38M)64K3.86M2.75M434K
Net Income(176.33M)(270.43M)(675.16M)(208.14M)(95.7M)
Net Margin-69.8%-97.6%-260.6%-81.8%-38.4%
EPS (Basic)(13.88)(19.68)(47.50)(13.88)(5.96)
EPS (Diluted)(13.88)(19.68)(47.50)(13.88)(5.96)
Weighted Avg Shares12.7M13.71M14.21M15M16.05M
Weighted Avg Shares (Diluted)12.7M13.71M14.21M15M16.05M

American Well Corporation

NYSE:AMWL

Intrinsic Alpha fair value

Locked

Current Price

$11.03

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.